Health and FitnessHealth and Fitness
Mon, May 6, 2013
[ Mon, May 06th 2013 ] - Market Wire
Drinking is Believing

Highline Research Advisors initiates coverage on Trovagene (NASDAQ:TROV) with a buy rating.


Published on 2013-05-06 07:00:22 - Market Wire
  Print publication without navigation


Highline Research Advisors initiates coverage on Trovagene (NASDAQ:TROV) with a buy rating. -- NEW YORK, May 6, 2013 /PRNewswire/ --

NEW YORK, May 6, 2013 /PRNewswire/ -- Today Highline Research Advisors initiated coverage through Empire Asset Management Company, a FINRA member (143007) of Trovagene (NASDAQ: [ TROV ]) with a BUY rating and 12 month price target of $17.00

SOURCE Empire Asset Management Company